CoChat

The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis

Open access

The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.

Abstract

Background Reference intervals of thyroid-stimulating hormone (TSH) and free thyroxine (FT 4 ) are statistically defined by the 2·5–97·5th percentiles, without accounting for potential risk of clinical outcomes. We aimed to define the optimal healthy ranges of TSH and FT 4 based on the risk of cardiovascular disease and mortality. Methods This systematic review and individual participant data (IPD) meta-analysis identified eligible prospective cohorts through the Thyroid Studies Collaboration, supplemented with a systematic search via Embase, MEDLINE (Ovid), Web of science, the Cochrane Central Register of Controlled Trials, and Google Scholar from Jan 1, 2011, to Feb 12, 2017 with an updated search to Oct 13, 2022 (cohorts found in the second search were not included in the IPD). We included cohorts that collected TSH or FT 4 , and cardiovascular outcomes or mortality for adults (aged ≥18 years). We excluded cohorts that included solely pregnant women, individuals with overt thyroid diseases, and individuals with cardiovascular disease. We contacted the study investigators of eligible cohorts to provide IPD on demographics, TSH, FT 4 , thyroid peroxidase antibodies, history of cardiovascular disease and risk factors, medication use, cardiovascular disease events, cardiovascular disease mortality, and all-cause mortality. The primary outcome was a composite outcome including cardiovascular disease events (coronary heart disease, stroke, and heart failure) and all-cause mortality. Secondary outcomes were the separate assessment of cardiovascular disease events, all-cause mortality, and cardiovascular disease mortality. We performed one-step (cohort-stratified Cox models) and two-step (random-effects models) meta-analyses adjusting for age, sex, smoking, systolic blood pressure, diabetes, and total cholesterol. The study was registered with PROSPERO, CRD42017057576. Findings We identified 3935 studies, of which 53 cohorts fulfilled the inclusion criteria and 26 cohorts agreed to participate. We included IPD on 134 346 participants with a median age of 59 years (range 18–106) at baseline. There was a J-shaped association of FT 4 with the composite outcome and secondary outcomes, with the 20th (median 13·5 pmol/L [IQR 11·2–13·9]) to 40th percentiles (median 14·8 pmol/L [12·3–15·0]) conveying the lowest risk. Compared with the 20–40th percentiles, the age-adjusted and sex-adjusted hazard ratio (HR) for FT 4 in the 80–100th percentiles was 1·20 (95% CI 1·11–1·31) for the composite outcome, 1·34 (1·20–1·49) for all-cause mortality, 1·57 (1·31–1·89) for cardiovascular disease mortality, and 1·22 (1·11–1·33) for cardiovascular disease events. In individuals aged 70 years and older, the 10-year absolute risk of composite outcome increased over 5% for women with FT 4 greater than the 85th percentile (median 17·6 pmol/L [IQR 15·0–18·3]), and men with FT 4 greater than the 75th percentile (16·7 pmol/L [14·0–17·4]). Non-linear associations were identified for TSH, with the 60th (median 1·90 mIU/L [IQR 1·68–2·25]) to 80th percentiles (2·90 mIU/L [2·41–3·32]) associated with the lowest risk of cardiovascular disease and mortality. Compared with the 60–80th percentiles, the age-adjusted and sex-adjusted HR of TSH in the 0–20th percentiles was 1·07 (95% CI 1·02–1·12) for the composite outcome, 1·09 (1·05–1·14) for all-cause mortality, and 1·07 (0·99–1·16) for cardiovascular disease mortality. Interpretation There was a J-shaped association of FT 4 with cardiovascular disease and mortality. Low concentrations of TSH were associated with a higher risk of all-cause mortality and cardiovascular disease mortality. The 20–40th percentiles of FT 4 and the 60–80th percentiles of TSH could represent the optimal healthy ranges of thyroid function based on the risk of cardiovascular disease and mortality, with more than 5% increase of 10-year composite risk identified for FT 4 greater than the 85th percentile in women and men older than 70 years. We propose a feasible approach to establish the optimal healthy ranges of thyroid function, allowing for better identification of individuals with a higher risk of thyroid-related outcomes. Funding None.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(23)00227-9

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Cited by

See all 61

Metadata

Authors
Xu, Y., Derakhshan, A., Hysaj, O., Wildisen, L., Ittermann, T., Pingitore, A., Abolhassani, N., Medici, M., Kiemeney, L. A. L. M., Riksen, N. P., Dullaart, R. P. F., Trompet, S., Dörr, M., Brown, S. J., Schmidt, B., Führer-Sakel, D., Vanderpump, M. P. J., Muendlein, A., Drexel, H., Fink, H. A., Ikram, M. K., Kavousi, M., Rhee, C. M., Bensenor, I. M., Azizi, F., Hankey, G. J., Iacoviello, M., Imaizumi, M., Ceresini, G., Ferrucci, L., Sgarbi, J. A., Bauer, D. C., Wareham, N., Boelaert, K., Bakker, S. J. L., Jukema, J. W., Vaes, B., Iervasi, G., Yeap, B. B., Westendorp, R. G. J., Korevaar, T. I. M., Völzke, H., Razvi, S., Gussekloo, J., Walsh, J. P., Cappola, A. R., Rodondi, N., Peeters, R. P., & Chaker, L.
Affiliations
  • Erasmus MC (NL)
  • University of Bern (CH)
  • Universitätsmedizin Greifswald (DE)
  • Istituto di Fisiologia Clinica (IT)
  • Radboud University Nijmegen (NL)
  • Radboud University Medical Center (NL)
  • University Medical Center Groningen (NL)
  • Leiden University Medical Center (NL)
  • Sir Charles Gairdner Hospital (AU)
  • University of Duisburg-Essen (DE)
  • Vorarlberg Institute for Vascular Investigation and Treatment (AT)
  • Private University in the Principality of Liechtenstein (LI)
  • University of Minnesota (US)
  • University of California, Irvine (US)
  • Research Institute for Endocrine Sciences (IR)
  • The University of Western Australia (AU)
  • Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT)
  • Radiation Effects Research Foundation (JP)
  • Ospedale di Parma (IT)
  • National Institute on Aging (US)
  • Faculdade de Medicina de Marília (BR)
  • University of California, San Francisco (US)
  • University of Birmingham (GB)
  • KU Leuven (BE)
  • University of Copenhagen (DK)
  • Newcastle University (GB)
  • University of Pennsylvania (US)
Corresponding author
Chaker, Layal
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2023-10
Volume
11
Issue
10
Pages
743-754
ISSN
2213-8587 (ISSN-L)
OpenAlex
W4386553499
Cited by
61
References
69
Citations by year
2026: 14 · 2025: 27 · 2024: 15 · 2023: 5
FWCI
2.19
Type
journal article
Language
en
Open access
Locations
  • The Lancet Diabetes & Endocrinology (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by-nc-nd)
  • Lirias (submittedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
  • Apollo
  • Open Access CRIS of the University of Bern
Funders
  • National Science Foundation
  • Amgen
  • Eli Lilly and Company
  • Pfizer
  • Sanofi
  • Edwards Lifesciences
  • Boston Scientific Corporation
  • Merck KGaA
  • Amarin Corporation
  • Cancer Research UK (C864/A14136)
  • Deutsche Forschungsgemeinschaft (JO-170/8-1, SI 236/8–1, 236/8-1, SFB/TR 296, HO 3314/2-1, ER 155/6-1, EI 969/2-3, INST 58219/32-1, PE 2309/2-1, KN885/3-1)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (200606)
  • Bundesministerium für Bildung und Forschung (01EG0401, 01ER1001D, 01GS0820_WB2-C, 01GI0860, 01GI0856, 01GI0205)
  • Novo Nordisk (NNF17OC0027812)
  • Novo Nordisk Fonden (NNF17OC0027812)
  • Heinz Nixdorf Stiftung (SI 236/8-1, ER 155/6-1)
  • Spinnaker Health Research Foundation
  • National Institutes of Health (N01-AG-6-2103, n01hc085082-026, n01hc085081-021, HHSN268201800001C, n01hc085079-024, n01hc085083-027, n01hc085080-026, N01‐AG‐6‐2106, n01hc085086-022, HHSN268200800007C, N01-AG-6-2101, 75N92021D00006, Z99 AG999999, HHSN268201200036C, n01hc055222-001, N01HC85086, N01-HC-85082, N01HC85079, N01HC85080, N01HC85083, N01-HC-85081, UL1TR002369)
  • Medical Research Council (MC_UU_12015/1, C864/A14136, MR/N003284/1, MC_UU_00006/1))
  • National Health and Medical Research Council
  • Netherlands Heart Institute
  • National Institute on Aging (N01‐AG‐6–2101, R01‐NR012459, N01HC85081, N01HC85079, U01AG042145, N01-HC-85080, N01-HC-85082, R01AG066671, U01AG042168, R01AG028050, R01AG032317, AG042140, N01HC55222, HHSN268200800007C, AG042139, U01AG042143, R01AG027012, AG042168, U01AG027810, AG042124, N01-HC-85083, AG042145, 75N92021D00006, U01AG042139, N01AG62106, U01AG042124, K24AG042765, AG027810, U01AG042140, N01‐HC‐85086, R01AG023629, AG042143, HHSN268201800001C, N01-AG-62103, HHSN268201200036C)
  • National Heart, Lung, and Blood Institute (N01-HC-85081, N01 HC085086, N01HC-85083, 75N 92021D00006, R01-NR012459, N01 HC085079, N01 HC085083, N01HC85082, N01 HC85086, N01 HC085080, HHSN 268200800007C, HHSN268201800001C, N01HC85080, U01HL130114, N01AG62101, N01 HC55222, N01AG62106, HHSN268201200036C, N01HC085082, U01HL080295, N01 HC055222, N01AG62103, N01 HC085081, N01-HC85079)
  • National Institute of Nursing Research (N01-AG-6–2101, N01-AG-6-2103, N01-AG-6–2106, R01NR012459)
  • National Institute of Neurological Disorders and Stroke (N01-AG-6-2106, N01-AG-6-2103, R01-NR012459, HHSN268200800007C, N01-HC-85080, N01-HC-85083, HHSN268201800001C, N01HC85082, 75N92021D00006, N01-AG-6-2101, N01-HC-85081, R01-AG028050, N01-HC-85086, N01 HC-55222, N01HC85079, HHSN268201200036C)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (U01AR066160, AR066160)
  • National Center for Advancing Translational Sciences (TR002369)
  • Daiichi Sankyo Europe
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
thyroid-stimulating hormone, free thyroxine, cardiovascular disease, all-cause mortality, cardiovascular mortality, J-shaped association, thyroid peroxidase antibodies, thyroid autoimmunity, coronary artery disease, stroke, heart failure
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Female, Humans, Male, Middle Aged, Pregnancy, Prospective Studies, Thyroid Function Tests, Thyroid Gland, Thyrotropin, Thyroxine, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis. https://app.cochat.ai/papers/10.1016/s2213-8587(23)00227-9
The paper
Xu, Y., Derakhshan, A., Hysaj, O., Wildisen, L., Ittermann, T., Pingitore, A., Abolhassani, N., Medici, M., Kiemeney, L. A. L. M., Riksen, N. P., Dullaart, R. P. F., Trompet, S., Dörr, M., Brown, S. J., Schmidt, B., Führer-Sakel, D., Vanderpump, M. P. J., Muendlein, A., Drexel, H., . . . Chaker, L. (2023). The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(23)00227-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.